Table 3

Use of Therapies in Patients With Acute Myocardial Infarction According to Occurrence of Heart Failure: Worcester Heart Attack Studylegend

HF Present (n = 2,558)HF Absent (n = 4,240)p Value
Therapies Maintained or Initiated During Acute Hospitalization (%)
 ACE inhibitors42.813.4< 0.001
 Antiplatelet agents36.747.6< 0.001
 Beta2+blockers37.755.5< 0.001
 CA blockers46.348.20.28
 Digoxin37.311.7< 0.001
 Thrombolytics21.227.6< 0.001
Discharge Medications (%)
 ACE inhibitors28.59.3< 0.001
 Antiplatelet agents24.036.8< 0.001
 Beta blockers25.047.5< 0.001
 CA2+blockers27.036.1< 0.001
 Digoxin28.08.8< 0.001
Procedures (%)
 Cardiac catheterization18.020.7< 0.01
 CABG2.31.90.28
 PTCA6.88.6< 0.04
  • Data available for the period 1990–1995;

  • Data available for the period 1986–1995.

  • legend HF = heart failure.